Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding

Meloni, Mario;Puligheddu, Monica;Carta, Manolo;Figorilli, Michela;Defazio, Giovanni
Ultimo
2020-01-01

Abstract

Several studies have indicated that altered serotonergic neurotransmission may contribute to non-motor features commonly associated with Parkinson's disease (PD) such as apathy and depression.The 5-Hydroxytryptophan (5-HTP) is the intermediate metabolite of L-tryptophan in the production of serotonin. To date, there has been inconsistent research on the use of 5-HTP in PD. The purpose of this study was to compare the effects of 5-HTP to placebo on apathy and depressive symptoms in patients with PD.
2020
Inglese
27
5
779
786
8
Esperti anonimi
scientifica
5-hydroxytryptophan; Parkinson’s disease; Apathy; Depression
no
Meloni, Mario; Puligheddu, Monica; Carta, Manolo; Cannas, Antonino; Figorilli, Michela; Defazio, Giovanni
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
6
reserved
File in questo prodotto:
File Dimensione Formato  
2020 Efficacy and safety.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 362.24 kB
Formato Adobe PDF
362.24 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie